Abstract
Background:
Evidence-based Standards for Psychosocial Care for Children with Cancer and their Families were published in 2015. Determining how often care delivery practices and approaches align with the Standards is important for understanding the reach of the Standards.
Procedure:
Medical (n = 73) and psychosocial (n = 99) providers from 129 of 197 (65%) Children’s Oncology Group (COG) programs in the United States completed an online survey. Participants reported the frequency, timing, and psychosocial care delivery approaches for each Standard. Program size was considered, and the data were compared with those from a similar 2016 survey.
Results:
Using a 5-point scale, services consistent with the Standards are provided across programs—mean frequencies of 3.29–4.61 (5-point scale). Standards related to screening and monitoring (M = 4.42) are delivered more often than Standards related to intervention and support (M = 4.25), supportive care and bereavement (M = 3.88), and family and community (M = 3.72) (p < 0.001). Ratings of quality of care are near the midpoint of the scale. Findings are consistent with a 2016 report, although care related to family and community support was less frequent in 2023. Program size and provider discipline were not associated with quality or frequency.
Conclusions:
Providers report that psychosocial care aligned with the Standards is generally provided and perceive quality of care positively. Variability in types of care, frequency, and quality, and lack of change from when the Standards were first published, highlight the importance of improving the implementation of evidence-based approaches.
Keywords: pediatric oncology, psychosocial, standards of care
1. Introduction
Psychosocial support for children with cancer and their families is an essential component of comprehensive care [1–3]. The Standards for Psychosocial Care for Children with Cancer and Their Families (Standards [4]), were developed by more than 80 multidisciplinary pediatric oncology professionals and patient and family advocates with support from the Mattie Miracle Foundation (www.mattiemiracle.com). Each Standard is based on a rigorous, systematic literature review, including independent appraisal of the body of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.
Fourteen (the 15th standard is not discussed in this paper as it pertains to training, credentialing, supervision, and other aspects of professional practice) Standards are organized in four groups (Figure 1): (i) Asking and Monitoring: Assessment of psychosocial needs (PSS1 [5]); assessment of financial needs (PSS5 [6]); monitoring of neurocognitive problems (PSS2 [7]); facilitating adherence to treatment (PSS12 [8]); and screening in long-term survivorship (PSS3 [9]). (ii) Intervention and Support: Psychoeducation, information and anticipatory guidance (PSS7 [10]); preparatory information for procedures (PSS8 [11]); and psychosocial support and interventions (PSS4 [12]). (iii) Family and Community: opportunities for social interaction (PSS9 [13]); school support (PSS11 [14]); parental mental health (PSS6 [15]); and sibling support (PSS10 [16]). (iv) Supportive Care and Bereavement: Palliative care/end-of-life care (PSS13 [17]); and bereavement care (PSS14 [18]). The full set is in Supporting Information S1.
FIGURE 1.

Standards for the psychosocial care of children with cancer and their families.
After the publication of the Standards, a survey of Children’s Oncology Group (COG) sites across the United States (US), the Preparing to Implement the Standards: Psychosocial Services and Staffing (PIPS-CSS) study [19], showed most programs had a social worker and a child life specialist, although the full complement of psychosocial staff members was not consistently available. Overall, psychosocial care was provided for each Standard; however, the approaches and the extent to which care was delivered to all patients and families varied [20]. An institutional scoring system (Matrix) and accompanying Guidelines [21] were published and used to evaluate the inclusion of each Standard and improve implementation [22, 23].
The current study, Implementing the Standards Together—Engaging Parents and Providers in Psychosocial care (iSTEPPP), aims to further accelerate implementation of approaches aligned with the Standards by assessing practice change since the Standards were published. The staffing data from iSTEPPP are similar to 2016 PIP-CSS data, but show some incremental increases in the size of the psychosocial team (e.g., social work, psychology, neuropsychology, psychiatry), and an increase in Spanish-speaking psychosocial staff [24].
In the current paper, we use iSTEPPP data to describe how medical and psychosocial providers in pediatric oncology treatment programs in the United States report providing psychosocial care aligned with the Standards, and detail the timing and approaches utilized. We examined differences by the size of program, type of provider, and compared PIPS-CSS and iSTEPPP data to assess changes from 2016 to 2023.
2. Method
2.1. Study Design, Sample, and Recruitment
The iSTEPPP study is a collaborative research initiative with pediatric oncology patient and family advocates [25]. The sample description, recruitment, survey questionnaire development, and data on the size of the programs are described in Scialla et al. [24]. All study procedures were reviewed by the Nemours Institutional Review Board (IRB), which granted a waiver of documentation of informed consent and determined the study to be exempt from further IRB review. The data in the current paper are based on survey questions that are identical to the PIPS-CSS study [20]. Using the same survey questions allowed for comparisons across time, an a priori goal of the study.
2.2. Measures
2.2.1. Overall Quality of Care—Provider Report
Psychosocial and medical providers responded to an item about the overall quality of psychosocial care (“The psychosocial care that pediatric cancer patients/families receive in our program is comprehensive” and “state of the art.”) on a 5-point scale from “strongly disagree” (1) to “strongly agree” (5), with a midpoint (3) indicating “neutral.”
2.2.2. Implementation of the Standards—Provider Report
Psychosocial and medical providers (one of each per site) responded to a statement about psychosocial care for each Standard, indicating how often these services are provided on a 5-point scale, from Never (1) to Always (5), with the midpoint (3) indicating “sometimes.”
2.2.3. Approaches Used and Timing of Care—Provider Report
Psychosocial providers indicated specific approaches used to meet the Standards. They could check all responses that applied (e.g., structured interview, questionnaire). Participants could also write in how they met each Standard. For most of the Standards, they also selected when the services were provided (e.g., at diagnosis, within the first week).
2.3. Data Analysis
Survey responses were collected in REDCap [26]) and imported into SPSS [27]. All analyses were conducted using SPSS and Stata 18.5 (StataCorp LLC, College Station, Texas). We first reported the broadest evaluation of psychosocial care, whether providers perceive care as comprehensive and state-of-the-art. We used a Likert-type scale from 1 (strongly disagree) to 5 (strongly agree) for the full sample and medical and psychosocial providers separately. A Mann–Whitney U test assessed the differences between medical and psychosocial providers.
The frequency of care delivery of each of the 14 Standards was rated on a 1 (never) to 5 (always) Likert-type scale. Mean frequencies for each Standard were calculated for the full sample, and medical providers and psychosocial staff separately. Differences in mean frequencies for each Standard based on the discipline of the respondent were tested using the Mann–Whitney U test, correcting for multiple comparisons by Bonferroni adjustment of p < 0.01. Mean frequencies for the four groups of Standards (Asking and Monitoring, Intervention and Support, Family and Community, Supportive Care and Bereavement) were compared using the Skillings–Mack test and adjusting p-values with the Bonferroni method for multiple comparisons.
We examined the association of the size of the program (number of new patients in 2022) with provider perceptions of care as comprehensive and with the rating of each Standard using multilevel ordered logistic regression models. We adjusted the criterion for multiple comparisons to a p-value of 0.01. To understand differences between the 2016 PIPS-CSS data and the 2023 iSTEPPP data, responses to questions related to the comprehensiveness of care and the frequency of care provided for each Standard were tested using the Mann–Whitney U test.
3. Results
3.1. Participants
Participants were medical (n = 69) and psychosocial (n = 99) providers representing 129 of 197 US COG pediatric oncology treatment programs ([28]; institutional response rate 65.5%) from 45 geographically dispersed states and the District of Columbia (Figure 2). Each program identified up to two participants (one medical and one psychosocial provider) to complete the survey. Fifty-four programs (41.9%) returned data from both a medical and a psychosocial provider. Programs of all sizes (number of new patients in 2022): <50 (n = 33, 27%); 50–100 (n = 45, 36%); 101–250 (n = 30, 25%); >250 (n = 12, 10%) were represented.
FIGURE 2.

Map of the United States showing COG (Children’s Oncology Group) site and iSTEPPP (Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care) participation status.
3.2. Quality of Psychosocial Care
With respect to whether psychosocial care in their programs was comprehensive and state-of-the-art, ratings of medical and psychosocial providers were not significantly different. The means for both groups were near the midpoint of 3 on the 5-point scale of 1 (strongly disagree) to 5 (strongly agree): 3.25 (2.98–3.53) for medical, 3.11 (2.86–3.37) for psychosocial providers, and 3.17 (2.98–3.36) for the full sample. There was, however, notable variability in the responses to this item (Figure 3). While close to half of the medical (46.9%) and psychosocial (46.0%) providers indicated that they “agree” or “strongly agree” with this statement, about one-third of both medical (29.7%) and psychosocial (34.5%) providers indicated that they “disagree” or “strongly disagree” (Figure 2). There was no significant association of program size and provider ratings of quality of care (p > 0.01).
FIGURE 3.

Endorsement of “comprehensive and state-of-the-art” care by medical and psychosocial providers.
3.3. Mean Frequencies of Care Provided by Each Standard
The mean frequencies across the Standards ranged from 3.29 (sometimes) to 4.61 (usually) on a 1 (never) to 5 (always) scale (Table 1). There were no differences between medical and psychosocial providers (p-values >0.01). There was, however, variability in mean frequency for the four groups of Standards (Skillings–Mack = 196.58, p < 0.001). Standards related to Asking and Monitoring (M = 4.42) are delivered more often than Intervention and Support (M = 4.25), Supportive Care and Bereavement (M = 3.88), and Family and Community (M = 3.72).
TABLE 1.
Mean frequency of care/service provided by psychosocial and medical providers on a 1 (Never) to 5 (Always) scale.
| Standard (number) | All (n = 168) Mean (SD) |
Psychosocial (n = 99) Mean (SD) |
Medical (n = 69) Mean (SD) |
|---|---|---|---|
| Asking and Monitoring (M = 4.42) | |||
| Assessment of psychosocial healthcare needs (PSS1) | 4.61 (0.61) | 4.59 (0.62) | 4.65 (0.59) |
| Assessment of financial need (PSS5) | 4.52 (0.67) | 4.59 (0.66) | 4.41 (0.68) |
| Monitoring of neurocognitive problems (PSS2) | 4.28 (0.91) | 4.38 (0.82) | 4.15 (1.02) |
| Adherence to treatment is assessed and monitored (PSS12) | 4.41 (0.72) | 4.29 (0.80) | 4.58 (0.56) |
| Screening in long-term survivorship (PSS3) | 4.24 (0.94) | 4.30 (0.91) | 4.15 (0.97) |
| Intervention and Support (M = 4.25) | |||
| Psychoeducation, information, anticipatory guidance (PSS7) | 4.43 (0.79) | 4.52 (0.68) | 4.30 (0.91) |
| Preparatory information about invasive procedures (PSS8) | 4.17 (0.81) | 4.21 (0.75) | 4.12 (0.89) |
| Psychosocial interventions for invasive procedures (PSS8) | 3.81 (0.86) | 3.88 (0.85) | 3.70 (0.86) |
| Psychosocial support and Interventions (PSS4) | 4.48 (0.67) | 4.53 (0.62) | 4.39 (0.74) |
| Family and Community (M = 3.72) | |||
| Opportunities for social interaction (PSS9) | 3.46 (0.77) | 3.37 (0.83) | 3.59 (0.66) |
| Support for school re-entry (PSS11) | 4.27 (0.74) | 4.29 (0.74) | 4.23 (0.75) |
| Parental mental health (PSS6) | 3.84 (0.93) | 3.86 (1.01) | 3.81 (0.81) |
| Psychosocial support and interventions for siblings (PSS10) | 3.29 (0.84) | 3.29 (0.89) | 3.28 (0.77) |
| Supportive Care and Bereavement (M = 3.88) | |||
| Palliative care concepts throughout disease process (PSS13) | 3.29 (0.87) | 3.25 (0.82) | 3.34 (0.93) |
| Developmentally appropriate end-of-life care (PSS13) | 4.51 (0.61) | 4.47 (0.61) | 4.57 (0.61) |
| Psychosocial care after a child’s death (PSS14) | 3.82 (0.96) | 3.82 (0.96) | 3.82 (0.96) |
Note: There are no significant differences in mean ratings across medical or psychosocial providers. There are no significant differences by the size of the program.
There were no significant associations of program size and frequency of care provided (p-values > 0.01). Table 2 summarizes approaches and timing of care by Standard.
TABLE 2.
Approaches used and timing of care related to the psychosocial standards.
| Asking and Monitoring | ||||
|---|---|---|---|---|
| Standard | Approach used | % | When is care provided | % |
| Youth with cancer and their family members should routinely receive systematic assessments of their psychosocial healthcare needs (PSS1) | Informal discussion with child/family | 85.3 | When a problem is identified | 79.8 |
| Structured interview | 54.1 | First week after diagnosis | 68.8 | |
| Psychosocial Assessment Tool (PAT) | 25.7 | At survivorship visits | 61.5 | |
| Other assessment tool or scale | 23.9 | Diagnosis (within 48 hours) | 51.4 | |
| Distress thermometer | 18.3 | First month after diagnosis | 47.7 | |
| Every inpatient admission | 46.8 | |||
| At end of active treatment | 35.8 | |||
| Every clinic visit | 26.6 | |||
| Other specific time points | 23.9 | |||
| Psychosocial staff should assess families’ financial needs, including factors that may influence their access to care (PSS5) | No data collected on approach for this Standard | First week after diagnosis | 62.4 | |
| When a problem is identified | 60.6 | |||
| Diagnosis (within 48 hours) | 40.4 | |||
| First month after diagnosis | 29.4 | |||
| Every inpatient admission | 25.7 | |||
| Other specific time points | 18.3 | |||
| Every clinic visit | 16.5 | |||
| Patients w/brain tumors and others at high risk for neuropsychological deficits should be monitored for deficits during and after treatment (PSS2) | Referral to neuropsychologist | 79.8 | When a problem is identified | 74.3 |
| Informal discussion | 73.4 | At survivorship visits | 56.9 | |
| Brief neurocognitive testing | 33.0 | At end of active treatment | 53.2 | |
| Other | 11.9 | Within 2 months after diagnosis | 36.7 | |
| Every clinic visit | 28.4 | |||
| Every inpatient admission | 16.5 | |||
| Other specific time points | 15.6 | |||
| Adherence should be assessed routinely and monitored throughout treatment (PSS12)a | Ask family members verbally | 84.4 | ||
| Ask patient verbally | 82.6 | |||
| Self-report (by the patient) | 67.0 | |||
| Self-report (by the parents) | 67.0 | |||
| Provider report (staff) | 63.3 | |||
| Ask medical providers verbally | 58.7 | |||
| Blood test | 56.9 | |||
| Medication log | 39.4 | |||
| Electronic monitoring device | 8.3 | |||
| Other | 6.4 | |||
| Psychosocial staff should monitor long-term childhood cancer survivors (PSS3)a | Informal discussion w/child/family | 73.4 | ||
| Screen for distress, anxiety, depression | 57.8 | |||
| Screen educational/vocational progress | 55.0 | |||
| Screen for social/relationship difficulties | 52.3 | |||
| Other | 8.3 | |||
| Interventions and Support | ||||
| Standard | Approach used | % | When is care provided | % |
| Psychosocial staff should provide psychoeducation, information, and anticipatory guidance regarding the child’s disease and treatment (PSS7)a | Meet with child and family | 86.2 | ||
| Meet with parent(s) wo child | 81.7 | |||
| Provide written materials | 80.7 | |||
| Meet individually with child | 79.8 | |||
| Provide access to resources online | 73.4 | |||
| Provide informational videos | 33.0 | |||
| Other | 8.3 | |||
| Psychosocial staff should provide preparatory information related to invasive medical procedures (PSS8a)a | Meet with child and family | 81.7 | ||
| Meet individually with child | 77.1 | |||
| Meet with parent(s) without child | 67.0 | |||
| Provide written materials | 61.5 | |||
| Provide informational videos | 44.0 | |||
| Provide access to resources online | 41.3 | |||
| Other | 10.1 | |||
| Psychosocial staff should provide psychological interventions for invasive medical procedures (PSS8b)a | Distraction | 84.4 | ||
| Relaxation | 79.8 | |||
| Cognitive/Behavioral therapy | 66.1 | |||
| Other | 11.9 | |||
| Hypnosis | 9.2 | |||
| Psychosocial staff should provide youth with cancer and their families with psychosocial support and intervention (PSS4) | Informal discussion child & family | 85.3 | When a problem is identified | 78.9 |
| Supportive psychotherapy | 79.8 | Within the first week | 66.1 | |
| Cognitive/Behavioral therapy | 69.7 | Within the first month | 56.9 | |
| Pharmacologic treatment | 61.5 | At diagnosis (within 48 hours) | 55.0 | |
| Problem solving skills training (PSST) | 35.8 | At survivorship visits | 49.5 | |
| Family Therapy | 33.9 | At every inpatient admission | 41.3 | |
| Support groups | 28.4 | At the end of active treatment | 40.4 | |
| Other | 15.6 | At every clinic visit | 25.7 | |
| SCCIP | 4.6 | At other specific time points | 12.8 | |
| Family and Community | ||||
| Standard | Approach used | % | When is care provided | % |
| Psychosocial staff should provide youth with cancer with opportunities for social interaction (PSS9)a | Camps | 68.8 | ||
| Facilitated activities/programs | 62.4 | |||
| Support groups | 22.9 | |||
| Other | 22.9 | |||
| Online groups/chat rooms | 20.2 | |||
| Psychosocial staff should provide patients with support for re-entry into school (PSS11)a | Staff person who coordinates w school | 68.8 | ||
| In-house school program | 45.9 | |||
| Other school services | 19.3 | |||
| Psychosocial staff should assess the mental health needs of parents/caregivers (PSS6) | Informal discussion w parents | 80.7 | When a problem is identified | 71.6 |
| Referral to therapist in community | 76.1 | Within the first week | 56.9 | |
| Referral to community psychiatrist | 60.6 | Within the first month | 48.6 | |
| Supportive psychotherapy | 56.9 | At diagnosis (within 48 hours) | 42.2 | |
| Referral to therapist in hospital | 39.4 | At survivorship visits | 31.2 | |
| Referral to psychiatrist in hospital | 33.9 | At every inpatient admission | 30.3 | |
| Cognitive/Behavioral Therapy | 31.2 | At end of active treatment | 25.7 | |
| Family therapy | 25.7 | At every clinic visit | 17.4 | |
| Support groups | 23.9 | At other specific time points | 8.3 | |
| Problem solving skills training | 19.3 | |||
| Couples/Marital Counseling | 11.9 | |||
| Other | 6.4 | |||
| SCCIP | 1.8 | |||
| Psychosocial staff should provide psychosocial support and intervention for siblings of patients (PSS10)a | Informal discussion w sibs/family | 78.0 | ||
| Referral community providers | 66.1 | |||
| Resource materials to parents | 59.6 | |||
| Supportive psychotherapy siblings | 35.8 | |||
| Sibling programs | 33.0 | |||
| Sibling support groups | 12.8 | |||
| Other | 7.3 | |||
| Supportive Care and Bereavement | ||||
| Standard | Approach used | % | When is care provided | % |
| Psychosocial staff should deliver care after a child’s death (PSS14) | Phone call to family to assess needs | 72.5 | ||
| Phone call to family to resources | 70.6 | |||
| Letter or card | 67.9 | |||
| Phone call to assess psychosocial status | 57.8 | |||
| Legacy items | 56.0 | |||
| Memorial programs at hospital | 54.1 | |||
| Support groups | 21.1 | |||
| In person meeting with family | 20.2 | |||
| Psychotherapy | 18.3 | |||
| Other | 9.2 | |||
Questions about timing were asked for a subset of Standards.
3.4. Asking and Monitoring
For the five Standards related to Asking and Monitoring, informal discussion or verbal reports were the most frequently endorsed approach (73.4%–85.3%). Validated screening tools were utilized less frequently. For example, 25.7% endorsed using the Psychosocial Assessment Tool [29] and 18.3% the Distress Thermometer [30]. The most frequent time for providing care was when a problem was identified for PSS1 (79.8%) and PSS2 (74.3%), and the first week after diagnosis for PSS5 (62.4%).
3.5. Intervention and Support
Informal discussions and supportive psychotherapy were frequently mentioned approaches. With respect to specific evidence-based approaches, there was endorsement of cognitive behavioral therapy across these Standards (66.1%–69.7%), family therapy (33.9%), and cancer-specific approaches such as Problem-Solving Skills Training [31] (35.8%), Surviving Cancer Competently Intervention Program (SCCIP; SCCIP-ND; [32, 33]) (4.6%). Psychopharmacologic treatment (i.e., psychotropic medication) was reported by 61.5%, reflecting its use for pre-existing mental health concerns or adverse psychological effects related to oncologic treatment for children and adults [34, 35]. Care is provided most often when problems are identified (79.8%), followed by within a week of diagnosis (66.1%). Care is less often provided at every inpatient encounter (41.3%) and at every outpatient visit (25.7%). With respect to psychoeducation and procedural support, sessions with individual patients are common across these Standards (67.0%–81.7%), along with joint sessions with family (81.7%–86.2%). Distraction (84.4%) and relaxation (79.8%) are often used for procedures. Written materials (61.5%–80.7%) augment interventions.
3.6. Family and Community
Programs reported providing patients with opportunities to connect with others via community-based camps (68.8%), support groups (22.9%), online chats (20.2%), and other programs (22.9%). Most cancer programs have a school liaison (68.8%) and/or a hospital-based school program (45.9%). Caring for the mental health needs of parents was accomplished primarily by informal discussion (80.7%), general psychological treatments, and referral to community providers (60.6%–76.1%). Similar to other Standards, identified concerns prompt intervention (71.6%). Sibling issues are most often handled in informal discussions (78.0%) and by referral to community providers (66.1%).
3.7. Supportive Care and Bereavement
The services related to the supportive care and bereavement Standards were noted to involve other hospital services or referral to community agencies, as the primary providers. Most programs send a card or letter (67.9%), or (57.8%) make a call after a child dies. Most have a hospital memorial service (54.1%). In-person meetings (20.2%), psychotherapy (18.3%), or support groups (21.1%) were less commonly offered.
3.8. Differences in Frequency of Care Provided: PIPS-CSS Versus iSTEPPP
The frequency of care provided between 2016 and 2023 (PIPS-CSS, iSTEPPP) was not significantly different for the individual Standards related to Asking and Monitoring, Intervention and Support, and Supportive Care and Bereavement (p-values >0.01) (Table 3). Three of the four Standards related to Family and Community showed a significant decrease in the frequency with which care was provided in iSTEPPP as compared to previously: Parental Mental Health PSS6 (M = 4.23, 95% CI = 4.13–4.33; M = 3.84, 95% CI = 3.69–3.99, respectively), Opportunities for Social Interaction PSS9 (M = 3.96, 95% CI = 3.85–4.07; M = 3.46, 95% CI = 3.34–3.58, respectively), and Siblings PSS10 (M = 3.65, 95% CI = 3.53–3.76; M = 3.29, 95% CI = 3.15–3.42, respectively).
TABLE 3.
Mean frequency of psychosocial care provided by Standard in 2016 (PIPS-CSS) and 2023 (iSTEPPP) studies on a 1 (Never) to 5 (Always) scale.
| Standard (number) | PIPS-CSS (n = 231) Mean (SD) |
iSTEPPPa (n = 168) Mean (SD) |
|---|---|---|
| Asking and Monitoring | ||
| Assessment of psychosocial healthcare needs (PSS1) | 4.62 (0.67) | 4.61 (0.61) |
| Assessment of financial need (at diagnosis) (PSS5) | 4.47 (0.83) | 4.52 (0.67) |
| Monitoring of neurocognitive problems (PSS2) | 4.15 (0.99) | 4.28 (0.91) |
| Adherence to treatment is assessed and monitored (PSS12) | 4.44 (0.74) | 4.41 (0.72) |
| Screening in long-term survivorship (PSS3) | 4.01 (1.06) | 4.24 (0.94) |
| Intervention and Support | ||
| Psychoeducation, information, anticipatory guidance (PSS7) | 4.36 (0.77) | 4.43 (0.79) |
| Preparatory information about invasive procedures (PSS8) | 4.14 (0.90) | 4.17 (0.81) |
| Psychosocial interventions for invasive procedures (PSS8) | 3.88 (0.91) | 3.81 (0.86) |
| Psychosocial support and interventions (PSS4) | 4.53 (0.66) | 4.48 (0.67) |
| Family and Community | ||
| Opportunities for social interaction (PSS9)b | 3.96 (0.82) | 3.46 (0.77) |
| Support for school re-entry (PSS11) | 4.29 (0.78) | 4.27 (0.74) |
| Parental mental health (PSS6)b | 4.23 (0.76) | 3.84 (0.93) |
| Psychosocial support and interventions for siblings (PSS10)b | 3.65 (0.87) | 3.29 (0.84) |
| Supportive Care and Bereavement | ||
| Palliative care concepts throughout disease process (PSS13a) | 3.19 (0.98) | 3.29 (0.87) |
| Developmentally appropriate end-of-life care (PSS13b) | 4.56 (0.65) | 4.51 (0.61) |
| Psychosocial care after a child’s death (PSS14) | 3.86 (0.94) | 3.82 (0.96) |
Note: p < 0.001.
There are no significant differences by size of program.
Significant difference in mean score between PIPS-CSS (2016) and iSTEPPP (2023).
4. Discussion
There is robust evidence for psychosocial care that encompasses a broad array of patient and family concerns, and evidence-based Standards that guide the provision of this care [4]. We conducted a national survey (in 2023) to determine staffing and services in collaboration with patient and family advocates [25]. We also had the unique opportunity to compare our current findings with those from a previous study [19, 20].
Medical and psychosocial providers agree that comprehensive and state-of-the-art care aligned with the Standards is provided at their sites, with the average level of endorsement being around the midpoint of 5-point scales. Thus, on average, providers appraised the quality of care as “neutral” and indicated it was “sometimes” provided. There is considerable variability, and approximately one-third of programs reported that they were not providing comprehensive care across the realms covered by the full set of Standards. Closely observing the individual Standards and the frequency and timing of the care provided gives valuable information. Care provided relevant to the four Standards associated with Asking and Monitoring (psychosocial assessment, financial need, survivorship, adherence, and neurocognitive testing) was more often provided than those Standards related to Intervention and Support, Family and Community, and Supportive Care and Bereavement.
With respect to Asking and Monitoring, assessing psychosocial well-being and risk is a critical first step to help show areas of need for the patient and family, thereby offering insights into specific interventions that can be provided for patients. There are evidence-based approaches for screening that can be completed by the child or family [29, 36–38]. Screening is recognized as promoting responsive clinical care and providing a roadmap for subsequent interventions tailored to the needs identified [39–42]. Similarly, assessing financial need helps assure that social determinants of health are considered in the delivery of care and allows for the provision of support to promote engagement with the healthcare setting [43–45]. Interventions to address this are available [46–48]. These two Standards are best implemented shortly after diagnosis and near entry into cancer care, although iSTEPPP data suggest that it is equally or more often provided at the point when a problem is identified. Screening for neurocognitive difficulties represents clinical care consistent with established research on neurotoxicity and care that improves educational performance [49, 50]. iSTEPPP data also suggest that neurocognitive screening is not routine and is often provided reactively when a problem is identified.
Monitoring treatment adherence provides needed input as to whether medical treatments are being delivered as intended, essential to overall outcomes and health equity [51]. With the increasing population of childhood cancer survivors, attention to psychosocial needs is one of the key aspects of late effects, including during the transition to adulthood [52]. Other frequently provided services are those related to the patient and the provision of psychoeducation, guidance, and interventions to facilitate coping during treatments and procedures. Some Standards bridge to other services such as palliative care [53] and bereavement programs [54, 55].
The least often provided Standards are those associated with Family and Community. The only statistically significant decline in the frequency of care since 2016 was in three of the four Standards in this group. The lack of psychosocial services for families, in particular parents and siblings, is worrisome and puzzling. Parent behavioral health concerns are prominent in this population [56–58], a caregiver priority [59], and associated with child quality of life [60]. The needs of siblings and the challenges in providing care have been recognized for many years [61, 62]. While understanding that the child is the patient in a pediatric setting, making it more difficult to focus on caregiver concerns, a contextual understanding of children and their development must recognize the importance of supporting parents and other children in the family. Family functioning relates to other Standards, including adherence to treatment [63]. Moreover, parents consistently express an interest in psychosocial care for themselves and siblings [64].
The details with respect to how and when psychosocial care is provided are critically important to understanding the nuances of care delivery. These data are complex and highly variable, but some generalizations can be made. First, the Standards are intended to be universal, proactive, and preventative. Unfortunately, the data suggest that care is often provided inconsistently and in response to an identified problem. The fact that “usually” or “always” was not endorsed more frequently raises questions as to whether all families are receiving comprehensive psychosocial care and whether care is provided with equity to all families [65]. Second, although we recognize that the Standards can be met in many ways, there are evidence-based treatments, supported by recent systematic reviews [66, 67] that are often not being offered [68]. Informal discussion was endorsed frequently across the Standards. While talking with patients and families is necessary in psychosocial care, it is not necessarily sufficient. It should not be used in lieu of evidence-based approaches that may require more specialized staff and additional training or resources to deliver. Moreover, relying on informal and unstandardized approaches may unintentionally communicate that more robust resources are not needed, exacerbating staffing and related challenges.
Alignment with the Standards and perceived quality of care do not differ by the size of programs. The intention across programs likely is to provide excellent and comprehensive care and that providers are working hard to achieve the spirit, if not always the detailed delivery of the Standards. However, there is clearly room for improvement. The frequency and quality of psychosocial care have not changed markedly since the Standards were published, despite a moderate increase in the size of psychosocial teams [24]. These findings are noted in the context of the COVID pandemic and increased mental health needs [69].
With its national scope and inclusion of COG sites from most states where most children receive their care, we intend that the data be used for benchmarking psychosocial care. We were unable to include programs in some rural states. It is also possible that programs with fewer resources or those without integrated psychosocial staff or supportive leadership may not have participated. The COVID-19 pandemic had a wide-ranging global impact on psychosocial care, and on families and providers [70–73] and may have curtailed use of the Matrix and Guidelines. Short- and long-term changes in practice and related influences over this time (e.g., telehealth, eHealth, staff shortages) may have had an ongoing impact on clinical practice, and increased attention to social determinants of health may have also impacted service provision and priorities. We also recognize the limitations of a broad provider survey, including potential biases of providers in rating care, and our inability to “verify” data due to limited information available in the public domain. We would be able to describe psychosocial care more fully had we been able to use a more focused approach to understand details of services provided, including the perspectives of families, and use qualitative methods. We also appreciate that nuances in the questions could be provided. For example, “comprehensive and state-of-the-art” care may be perceived differently and could be confounded by a single-item assessment. Initiatives in Australia, Canada, the Caribbean, and India are underway that will provide a broader perspective on the delivery of care globally and open avenues for cross-nation collaborations.
We conclude with some overarching questions important for future investigation: (i) how can we assure more consistency in psychosocial care within and across programs; (ii) how can all families receive care delivered with preventive rather than reactive approaches; (iii) how can pediatric cancer programs commit to and organize to implement the Standards; (iv) how can we assure a holistic vision of care inclusive of the needs of all members of the family; and (v) what implementation strategies can we introduce to facilitate uptake of the Standards? Recent research is promising in highlighting innovative ways in which psychosocial care can be provided. For example, McTate and colleagues [64] outline a comprehensive caregiver mental health program, Turner and colleagues [3] describe an interdisciplinary, tiered system of supports and services for children with cancer and their families, and Weiler-Wicht et al. [74] have pilot-tested a guide for children throughout their treatment. And providers and centers can access tools [21] to identify approaches and gauge their progress in providing care consistent with the Standards. Much work remains to be done to implement the vision of the Standards, particularly adding the voice of patients and families while also understanding barriers and facilitators of creative and effective approaches.
Supplementary Material
Supporting File 1: pbc31959-sup-0001-SuppMat.docx.
Additional supporting information can be found online in the Supporting Information section.
Acknowledgments
This research was supported by a grant from the Andrew McDonough B+ Foundation, with additional support from the Nemours Center for Healthcare Delivery Science and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The authors thank the many healthcare providers who participated in the study for their timely and thoughtful responses to the survey.
Abbreviations:
- COG
Children’s Oncology Group
- iSTEPPP
Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care
- NCCN
National Comprehensive Cancer Network
- PIPS-CSS
Preparing to Implement Psychosocial Standards: Current Services and Staffing
- PSS
Psychosocial Standard
- PSS1
Standard 1 Assessment of psychosocial healthcare needs
- PSS2
Standard 2 Monitoring of neuropsychological deficits
- PSS3
Standard 3 Screening in long-term survivorship
- PSS4
Standard 4 Psychosocial support and interventions
- PSS5
Standard 5 Assessment of financial need
- PSS6
Standard 6 Parental mental health
- PSS7
Standard 7 Psychoeducation, information, and anticipatory guidance
- PSS8
Standard 8 Preparatory information for procedures
- PSS9
Standard 9 Opportunities for social interaction
- PSS10
Standard 10 Siblings
- PSS11
Standard 11 School support
- PSS12
Standard 12 Adherence
- PSS13
Standard 13 Palliative care/end-of-life care
- PSS14
Standard 14 Bereavement care
- REDCap
Research Electronic Data Capture
- Standards
Standards for Psychosocial Care for Children with Cancer and Their Families
- US
United States
Footnotes
Conflicts of Interest
The authors declare no conflicts of interest.
References
- 1.National Academies of Sciences, Engineering, and Medicine, Comprehensive Cancer Care for Children and Their Families: Summary of a Joint Workshop by the Institute of Medicine and the American Cancer Society (National Academies Press, 2015). [PubMed] [Google Scholar]
- 2.Noll RB, Patel SK, Embry L, et al. , “Children’s Oncology Group’s 2013 Blueprint for Research: Behavioral Science,” Pediatric Blood & Cancer 60, no. 6 (2013): 1048–1054, 10.1002/pbc.24421. [DOI] [PubMed] [Google Scholar]
- 3.Turner E, Sirrine EH, Crabtree VM, et al. , “An Interprofessional Approach to Developing Family Psychosocial Support Programs in a Pediatric Oncology Healthcare Setting,” Cancers 17, no. 8 (2025): 1342, 10.3390/cancers17081342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wiener L, Kazak AE, Noll RB, Patenaude AF, and Kupst MJ, “Standards for the Psychosocial Care of Children with Cancer and Their Families: An Introduction to the Special Issue,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S419–S424, 10.1002/pbc.25675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kazak AE, Abrams AN, Banks J, et al. , “Psychosocial Assessment as a Standard of Care in Pediatric Cancer,” Pediatric Blood & Cancer 62, no. 5 (2015): S426–S459, 10.1002/pbc.25730. [DOI] [PubMed] [Google Scholar]
- 6.Pelletier W and Bona K, “Assessment of Financial Burden as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S619–S631, 10.1002/pbc.25714. [DOI] [PubMed] [Google Scholar]
- 7.Annett RD, Patel SK, and Phipps S, “Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S460–S513, 10.1002/pbc.25749. [DOI] [PubMed] [Google Scholar]
- 8.Pai AL and McGrady ME, “Assessing Medication Adherence as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S818–S828, 10.1002/pbc.25795. [DOI] [PubMed] [Google Scholar]
- 9.Lown EA, Phillips F, Schwartz LA, Rosenberg AR, and Jones B, “Psychosocial Follow-Up in Survivorship as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S514–S584, 10.1002/pbc.25783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Thompson AL and Young-Saleme TK, “Anticipatory Guidance and Psychoeducation as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S684–S693, 10.1002/pbc.25721. [DOI] [PubMed] [Google Scholar]
- 11.Flowers SR and Birnie KA, “Procedural Preparation and Support as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S694–S723, 10.1002/pbc.25813. [DOI] [PubMed] [Google Scholar]
- 12.Steele AC, Mullins LL, Mullins AJ, and Muriel AC, “Psychosocial Interventions and Therapeutic Support as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S585–S618, 10.1002/pbc.25701. [DOI] [PubMed] [Google Scholar]
- 13.Christiansen HL, Bingen K, Hoag JA, Karst JS, Velázquez-Martin B, and Barakat LP, “Providing Children and Adolescents Opportunities for Social Interaction as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S724–S749, 10.1002/pbc.25774. [DOI] [PubMed] [Google Scholar]
- 14.Thompson AL, Christiansen HL, Elam M, et al. , “Academic Continuity and School Reentry Support as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S805–S817, 10.1002/pbc.25760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kearney JA, Salley CG, and Muriel AC, “Standards of Psychosocial Care for Parents of Children with Cancer,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S632–S683, 10.1002/pbc.25761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gerhardt CA, Lehmann V, Long KA, and Alderfer MA, “Supporting Siblings as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S750–S804, 10.1002/pbc.25821. [DOI] [PubMed] [Google Scholar]
- 17.Weaver MS, Heinze KE, Kelly KP, et al. , “Palliative Care as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S829–S833, 10.1002/pbc.25695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lichtenthal WG, Sweeney CR, Roberts KE, et al. , “Bereavement Follow-Up After the Death of a Child as a Standard of Care in Pediatric Oncology,” Pediatric Blood & Cancer 62, no. Suppl 5 (2015): S834–S869, 10.1002/pbc.25700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Scialla MA, Canter KS, Chen FF, et al. , “Implementing the Psychosocial Standards in Pediatric Cancer: Current Staffing and Services Available,” Pediatric Blood & Cancer 64, no. 11 (2017): e26634, 10.1002/pbc.26634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Scialla MA, Canter KS, Chen FF, et al. , “Delivery of Care Consistent With the Psychosocial Standards in Pediatric Cancer: Current Practices in the United States,” Pediatric Blood & Cancer 65, no. 3 (2018): e26869, 10.1002/pbc.26869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wiener L, Kupst MJ, Pelletier W, Kazak AE, and Thompson AL, “Tools to Guide the Identification and Implementation of Care Consistent With the Psychosocial Standards of Care,” Pediatric Blood & Cancer 67, no. 9 (2020): e28586, 10.1002/pbc.28586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Foster K, Sadler B, Conrad AL, and Grafft A, “Development of an Evaluation Tool for Monitoring the Delivery of Psychosocial Care in Pediatric Oncology Settings,” Cancers 17, no. 9 (2025): 1550, 10.3390/cancers17091550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Jurbergs N, Elliott DA, Browne E, et al. , “How I Approach: Defining the Scope of Psychosocial Care Across Disciplines in Pediatric Hematology-oncology,” Pediatric Blood & Cancer 69, no. 9 (2022): e29809, 10.1002/pbc.29809. [DOI] [PubMed] [Google Scholar]
- 24.Scialla MA, Wiener L, Canter KS, et al. , “Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together-Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study,” Pediatric Blood & Cancer 72, no. 6 (2025): e31676, 10.1002/pbc.31676. [DOI] [PubMed] [Google Scholar]
- 25.Wiener L, Buff K, Canter K, et al. , “Partnership with Patient Advocacy Organizations Improves Research Recruitment,” Pediatric Blood & Cancer 72, no. 3 (2025): e31474, 10.1002/pbc.31474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Harris PA, Taylor R, Minor BL, et al. , “The REDCap Consortium: Building an International Community of Software Platform Partners,” Journal of Biomedical Informatics 95 (2019): 103208, 10.1016/j.jbi.2019.103208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.IBM Corp, “IBM SPSS Statistics for Windows (Version 27.0),” IBM Corp; 2020. [Google Scholar]
- 28.Children’s Oncology Group, “COG Institution Locations,” accessed May 5, 2025, https://www.childrensoncologygroup.org/apps/instmap/default.aspx.
- 29.Kazak AE, Hwang WT, Chen FF, et al. , “Screening for Family Psychosocial Risk in Pediatric Cancer: Validation of the Psychosocial Assessment Tool (PAT) Version 3,” Journal of Pediatric Psychology 43, no. 7 (2018): 737–748, 10.1093/jpepsy/jsy012. [DOI] [PubMed] [Google Scholar]
- 30.National Comprehensive Cancer Network, “NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Distress Management Version 1”, National Comprehensive Cancer Network, 2024, https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sahler OJ, Fairclough DL, Phipps S, et al. , “Using Problem-Solving Skills Training to Reduce Negative Affectivity in Mothers of Children With Newly Diagnosed Cancer: Report of a Multisite Randomized Trial,” Journal of Consulting and Clinical Psychology 73, no. 2 (2005): 272–283, 10.1037/0022-006X.73.2.272. [DOI] [PubMed] [Google Scholar]
- 32.Kazak AE, Simms S, Alderfer MA, et al. , “Feasibility and Preliminary Outcomes From a Pilot Study of a Brief Psychological Intervention for Families of Children Newly Diagnosed With Cancer,” Journal of Pediatric Psychology 30, no. 8 (2005): 644–655, 10.1093/jpepsy/jsi051. [DOI] [PubMed] [Google Scholar]
- 33.Kazak A, Alderfer M, Streisand R, et al. , “Treatment of Posttraumatic Stress Symptoms in Adolescent Survivors of Childhood Cancer and Their Families: A Randomized Clinical Trial,” Journal of Family Psychology 18 (2004): 493–504. [DOI] [PubMed] [Google Scholar]
- 34.Elliott DA and Harman JL, “How We Approach Steroid-induced Affective Disorder in Pediatric Oncology,” Pediatric Blood & Cancer 71, no. 12 (2024): e31324, 10.1002/pbc.31324. [DOI] [PubMed] [Google Scholar]
- 35.Gray NN, Villalobos LR, Matherne M, Schadler A, and Bosley TE, “Association of Chemotherapy Regimen Intensity and Use of Psychotropic Medications in Pediatric Oncology Patients,” Journal of Pediatric Pharmacology and Therapeutics 27, no. 7 (2022): 649–654, 10.5863/1551-6776-27.7.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gordon ML, Bedoya SZ, Fry A, et al. , “Beyond Presence of Symptoms: Self-Reported Psychosocial Distress Interference Among Outpatient Youth With Cancer and Other Life-Limiting Conditions,” Pediatric Blood & Cancer 71, no. 12 (2024): e31273, 10.1002/pbc.31273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Manikowski A, Williamson Lewis R, Bennett T, et al. , “Implementation of Electronic Psychosocial Screening among Caregivers in Pediatric Oncology,” JCO Oncology Practice 18, no. 7 (2022): e1198–e1208, 10.1200/OP.21.00836. [DOI] [PubMed] [Google Scholar]
- 38.Wiener L, Bedoya SZ, Gordon M, et al. , “Checking in: Development, Acceptability, and Feasibility of a Pediatric Electronic Distress Screener,” Clinical Practice in Pediatric Psychology 11, no. 1 (2023): 94–107, 10.1037/cpp0000450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Desjardins L, Hancock K, Szatmari P, et al. , “Protocol for Mapping Psychosocial Screening to Resources in Pediatric Oncology: A Pilot Randomized Controlled Trial,” Pilot and Feasibility Studies 7, no. 1 (2021): 143, 10.1186/s40814-021-00878-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kazak AE, Rourke MT, Alderfer MA, Pai A, Reilly AF, and Meadows AT, “Evidence-Based Assessment, Intervention, and Psychosocial Care in Pediatric Oncology: A Blueprint for Comprehensive Services Across Treatment,” Journal of Pediatric Psychology 32, no. 9 (2007): 1099–1110, 10.1093/jpepsy/jsm031. [DOI] [PubMed] [Google Scholar]
- 41.Kazak AE, Scialla M, Deatrick JA, and Barakat LP, “Pediatric Psychosocial Preventative Health Model: Achieving Equitable Psychosocial Care for Children and Families,” Families, Systems & Health: the Journal of Collaborative Family Healthcare 42, no. 1 (2024): 76–89, 10.1037/fsh0000856. [DOI] [PubMed] [Google Scholar]
- 42.Kazak AE, Swain AM, Canter K, et al. , “A Psychosocial Clinical Care Pathway for Pediatric Hematopoietic Stem Cell Transplantation,” Pediatric Blood & Cancer 66, no. 10 (2019): e27889, 10.1002/pbc.27889. [DOI] [PubMed] [Google Scholar]
- 43.Kazak AE, Scialla MA, Ramaswamy N, et al. , “Topical Review: Family Psychosocial Risk Screening and Social Determinants of Health Assessment,” Journal of Pediatric Psychology 50, no. 4 (2025): 320–325, 10.1093/jpepsy/jsaf006. [DOI] [PubMed] [Google Scholar]
- 44.Robles JM, Dressler EV, Kittel C, et al. , “Financial Distress Screening and Navigation in Pediatric Oncology within the National Cancer Institute Community Oncology Research Program,” JCO Oncology Practice 21, no. 5 (2025): 629–636, 10.1200/OP-24-00786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ruiz S, Hudson MM, Ehrhardt MJ, Maki J, Ackermann N, and Waters EA, “Childhood Cancer Survivors, Financial Toxicity, and the Need for Multilevel Interventions,” Pediatrics 152, no. 1 (2023): e2022059951, 10.1542/peds.2022-059951. [DOI] [PubMed] [Google Scholar]
- 46.Ping C, Andrade DC, Housten A, Doering M, Goldstein E, and Politi MC, “A Scoping Review of Interventions to Address Financial Toxicity in Pediatric and Adult Patients and Survivors of Cancer,” Cancer Medicine 14, no. 8 (2025): e70879, 10.1002/cam4.70879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Umaretiya PJ, Aziz-Bose R, Kelly C, and Bona K,, “Targeting Hardship: Poverty as a Modifiable Risk Factor in Childhood Leukemia and Lymphoma Treatment,” Hematology American Society of Hematology Education Program 2024, no. 1 (2024): 20–26, 10.1182/hematology.2024000527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zheng DJ, Shyr D, Ma C, Muriel AC, Wolfe J, and Bona K, “Feasibility of Systematic Poverty Screening in a Pediatric Oncology Referral Center,” Pediatric Blood & Cancer 65, no. 12 (2018): e27380, 10.1002/pbc.27380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Jacola LM, Partanen M, Lemiere J, Hudson MM, and Thomas S, “Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer,” Journal of Clinical Oncology 39, no. 16 (2021): 1696–1704, 10.1200/JCO.20.02444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Schofield HT, Fabrizio VA, Braniecki S, et al. , “Monitoring Neurocognitive Functioning after Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force,” Transplantation and Cellular Therapy 28, no. 10 (2022): 625–636, 10.1016/j.jtct.2022.06.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Rapoff MA, Duncan C, and Karlson C, “Strategies for Improving Adherence to Pediatric Medical Regimens,” in Adherence to Pediatric Medical Regimens (Issues in Clinical Child Psychology), (Springer, 2023), 10.1007/978-3-031-27484-8_8. [DOI] [Google Scholar]
- 52.Zhang A, Wang K, Zebrack B, Tan CY, Walling E, and Chugh R, “Psychosocial, Behavioral, and Supportive Interventions for Pediatric, Adolescent, and Young Adult Cancer Survivors: A Systematic Review and Meta-Analysis,” Critical Reviews in Oncology/Hematology 160 (2021): 103291, 10.1016/j.critrevonc.2021.103291. [DOI] [PubMed] [Google Scholar]
- 53.Weaver MS, Rosenberg AR, Tager J, Wichman CS, and Wiener L, “A Summary of Pediatric Palliative Care Team Structure and Services as Reported by Centers Caring for Children With Cancer,” Journal of Palliative Medicine 21, no. 4 (2018): 452–462, 10.1089/jpm.2017.0405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Bedoya S, Battles H, Gerhardt C, and Wiener L, “The End-of-Life Trajectory in Childhood Cancer: Bereaved Parents’ perceptions of the Availability, Use, and Helpfulness of Support Services,” Journal of Psychosocial Oncology Research and Practice 3, no. 2 (2021): e050, 10.1097/OR9.0000000000000050. [DOI] [Google Scholar]
- 55.Wiener L, Nautiyal P, McAdams S, and Zoosman M, “Making Space for Grief: The Impact of Remembrance Programs for Pediatric Healthcare Providers,” Palliative & Supportive Care 23 (2024): e9, 10.1017/S1478951524001457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Hu X, Grosse SD, Han X, Marchak JG, and Ji X, “Mental Health Care Utilization among Parents of Children with Cancer,” JAMA Network Open 7, no. 4 (2024): e244531, 10.1001/jamanetworkopen.2024.4531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Rosenberg AR, Dussel V, Kang T, et al. , “Psychological Distress in Parents of Children With Advanced Cancer,” JAMA Pediatrics 167, no. 6 (2013): 537–543, 10.1001/jamapediatrics.2013.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Salley CG, Axelrad M, Fischer E, and Steuer KB, “But Parents Need Help! Pathways to Caregiver Mental Health Care in Pediatric Hospital Settings,” Palliative and Supportive Care 21, no. 2 (2023): 347–353, 10.1017/S1478951522001353. [DOI] [PubMed] [Google Scholar]
- 59.Canter KS, Kazak AE, Koskela-Staples N, et al. , “Provider and Parent Perspectives on Essential Psychosocial Care in Pediatric Cancer,” JAMA Pediatrics, ahead of print, 2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bakula DM, Sharkey CM, Perez MN, et al. , “The Relationship Between Parent Distress and Child Quality of Life in Pediatric Cancer: A Meta-Analysis,” Journal of Pediatric Nursing 50 (2020): 14–19, 10.1016/j.pedn.2019.09.024. [DOI] [PubMed] [Google Scholar]
- 61.Brosnan P, Davis KA, Mazzenga M, et al. , “Psychosocial Care Providers’ Perspectives: Barriers to Implementing Services for Siblings of Children With Cancer,” Pediatric Blood & Cancer 69, no. 2 (2022): e29418, 10.1002/pbc.29418. [DOI] [PubMed] [Google Scholar]
- 62.Wawrzynski SE, Schaefer MR, Schvaneveldt N, and Alderfer MA, “Social Support and Siblings of Children With Cancer: A Scoping Review,” Psycho-Oncology 30, no. 8 (2021): 1232–1245, 10.1002/pon.5689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Psihogios AM, Fellmeth H, Schwartz LA, and Barakat LP, “Family Functioning and Medical Adherence across Children and Adolescents With Chronic Health Conditions: A Meta-Analysis,” Journal of Pediatric Psychology 44, no. 1 (2019): 84–97, 10.1093/jpepsy/jsy044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.McTate E, Szulczewski L, Joffe NE, Chan SF, and Pai ALH, “Implementation of the Psychosocial Standards for Caregiver Mental Health within a Pediatric Hematology/Oncology Program,” Journal of Clinical Psychology in Medical Settings 28, no. 2 (2021): 323–330, 10.1007/s10880-020-09719-3. [DOI] [PubMed] [Google Scholar]
- 65.Deatrick JA, Kazak AE, Scialla MA, et al. , “Advancing Health Equity in Pediatric Cancer Through Implementation of Universal family Psychosocial Risk Screening,” Psycho-Oncology 31, no. 9 (2022): 1483–1490, 10.1002/pon.5978. [DOI] [PubMed] [Google Scholar]
- 66.Koumarianou A, Symeonidi AE, Kattamis A, Linardatou K, Chrousos GP, and Darviri C, “A Review of Psychosocial Interventions Targeting Families of Children With Cancer,” Palliative & Supportive Care 19, no. 1 (2021): 103–118, 10.1017/S1478951520000449. [DOI] [PubMed] [Google Scholar]
- 67.Melesse TG, Chau JPC, and Nan MA,, “Effectiveness of Psychosocial Interventions on Health Outcomes of Children With Cancer: A Systematic Review of Randomised Controlled Trials,” European Journal of Cancer Care 31, no. 6 (2022): e13695, 10.1111/ecc.13695. [DOI] [PubMed] [Google Scholar]
- 68.Fair C, Thompson A, Barnett M, Flowers S, Burke J, and Wiener L, “Utilization of Psychotherapeutic Interventions by Pediatric Psychosocial Providers,” Children (Basel, Switzerland) 8, no. 11 (2021): 1045, 10.3390/children8111045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.American Academy of Pediatrics, “AAP-AACAP -CHA Declaration of a National Emergency in Child and Adolescent Mental Health,” American Academy of Pediatrics, updated October 19, 2021, https://www.aap.org/en/advocacy/child-and-adolescent-healthy-mental-development/aap-aacap-cha-declaration-of-a-national-emergency-in-child-and-adolescent-mental-health/. [Google Scholar]
- 70.Gopalakrishnan V, Veeraiah S, Chidambaram S, Sudhakar R, and Radhakrishnan V, “Caregiver’s Perspective on Psychosocial Issues of Paediatric Cancer Patients During COVID 19 Pandemic Lockdown,” Psycho-Oncology 31, no. 6 (2022): 1050–1053, 10.1002/pon.5967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Sniderman ER, Graetz DE, Agulnik A, et al. , “Impact of the COVID-19 Pandemic on Pediatric Oncology Providers Globally: A Mixed-methods Study,” Cancer 128 (2022): 1493–1502, 10.1002/cncr.34090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Tran A, Hou SHJ, Forbes C, et al. , “The Impact of the Early COVID-19 Global Pandemic on Children Undergoing Active Cancer Treatment and Their Parents,” Current Oncology (Toronto, Ont) 30, no. 2 (2023): 2441–2456, 10.3390/curroncol30020186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.van Gorp M, Maurice-Stam H, and Teunissen LC, “Psychosocial Function of Dutch Children With Cancer and Their Caregivers During Different Phases of the COVID-19 Pandemic,” Pediatric Blood & Cancer 69 (2022): e29535, 10.1002/pbc.29535. [DOI] [PubMed] [Google Scholar]
- 74.Weiler-Wichtl LJ, Schneider C, Gsell H, et al. , “Asking Those Who Know Their Needs Best: A Framework for Active Engagement and Involvement of Childhood Cancer Survivors and Parents in the Process of Psychosocial Research—A Workshop Report,” Cancer Reports (Hoboken, N.J.) 7 (2024): e2071, 10.1002/cnr2.2071. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting File 1: pbc31959-sup-0001-SuppMat.docx.
